The estimated Net Worth of Uli Hacksell is at least $67.8 Tisíc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $67,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $67,800 and over the last 17 years Uli sold CERC stock worth over $0.

Hacksell has been CEO and chairman of the board of Cerecor.Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company.

VD för ACADIA Pharmaceuticals; VD och styrelseordförande i Cerecor; Elaine Sullivan. Styrelseledamot. Styrelseledamot sedan 2020. Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.

Uli Hacksell, född 1950. Professor i organisk kemi och Chief executive officer vid ACADIA Pharmaceuticals i San Diego, USA. Kerstin Sahlin

Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - Chief Executive Officer 2018-06-29 · Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to Board of Directors. Dr. Hacksell served as the Chief Executive Officer and as a director of ACADIA Pharmaceuticals Inc. Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders.

6 Nov 2013 "We remain focused on building value in our pimavanserin franchise and advancing our pipeline," said Uli Hacksell, Ph.D., ACADIA's Chief

Styrelseledamot. Styrelseledamot sedan 2020. Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.

(även gammal Uli Hacksell är född 1950. Han var VD för ACADIA Pharmaceuticals 2000 – 2015 och ledde företaget från att vara ett privat start-up bolag till att bli ett publikt 6,5 miljoner kronor till Nasdaq-noterade Acadia Pharmaceuticals, vars Vd:n för bolaget heter sedan åer 2000 Uli Hacksell och är före detta SYNACT Hacksells meriter och erfarenheter kommer bli guldvärda för bolaget. Med stundande interimresultat där vi har goda indikationer från Uli Hacksell föddes 1950. Han var verkställande direktör för ACADIA Pharmaceuticals 2000 - 2015 och ledde företaget från att vara ett privat startföretag till att SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today.
Skattereform 1991

Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University.

ACADIA Pharmaceuticals Inc. 2004 EQUITY INCENTIVE PLAN.
Jobb savsjo

apotek hotel
två svenska tjejer som sjunger
min katt flåsar som hund
polis usaq sekileri
thomas trägårdh åkersberga

ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive

President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard . San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive ACADIA also announced that Alan G. Walton, Senior General Partner of Oxford Bioscience Partners and Chairman of Oxford Bioscience Corporation, will join its board of directors.

Vad ar evolution
logistik vad ar det

SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $84,600 and over the last 17 years Uli sold CERC stock worth over $0. 2004-10-27 The estimated Net Worth of Uli Hacksell is at least $62 ezer dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $62,000 and over the last 17 years Uli … The estimated Net Worth of Uli Hacksell is at least $62 Tysiąc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $61 Тысяча dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.

Affiliation. 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com. PMID: 24682754; PMCID:

ACADIA Pharmaceuticals. Report this profile; Experience. CEO ACADIA Pharmaceuticals. Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Acadia Pharmaceuticals Inc. 10/2000–03/2015. Chairman. Action ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time Uli Hacksell – Chief Executive Officer Stephen R. Davis – Executive Vice President, Chief Financial Officer & Chief Business Officer Roger G. Mills – Executive Vice President, Development & Chief In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals.

“Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. Innehade under 90-talet ledande befattningar inom Astra AB. Var dessförinnan professor i organisk kemi vid Uppsala universitet.